SLC22A6 and Fanconi renotubular syndrome: Long-term low-dose ADV use has been linked to Fanconi syndrome, potentially due to overexpression of OAT1 and inhibition of MRP (Izzedine et al., 2005; Tanji et al., 2001; Viganò et al., 2011).